Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/01/2008CN101275143A Nucleic acid encoding hyaluronan synthase and methods of use
10/01/2008CN101275133A DNA sequence of IER5-coded SiRNA, vector and application thereof
10/01/2008CN101275124A Recombinant bacterial phytases and uses thereof
10/01/2008CN101275123A 2-methyl-6-phytyl-1, 4-benzoquinone methyl transferase, coding genes thereof and application thereof
10/01/2008CN101275121A In vitro culture-amplified human liver progenitor cell and preparation thereof
10/01/2008CN101275120A Formula of inducing solution for marrow stromal cells culture and use method thereof
10/01/2008CN101274963A Anti-CD86 humanized monoclonal antibody
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN101273983A Use of neurocyte differentiated from stem cell induced by isobavachin
10/01/2008CN101273709A Tissue culture method for rapid propagation of Dendrobium candidum
10/01/2008CN100422335C Sequence regulating anther-specific expression of gene and its use in production of androsterile plants and hybrid seeds
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422329C Method for preparing immortalized cell of protein for expressing gene code of infective buresa of Fabricius virus
10/01/2008CN100422327C Expressed ag2 promotor in cotton inducted by glyphosate
10/01/2008CN100422321C Disease-resistant plants and method of constructing the same
10/01/2008CN100422317C Ouiescent cell populations for nuclear transfer
10/01/2008CN100422316C Neutralizing human anti-IGFR antibody
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
10/01/2008CN100422314C Method for obtaining Brassica oleracea var. acephala DC. small spore regenerated plants and special culture medium
10/01/2008CN100422214C Emitter-binding peptides that produce a change in the spectral emission properties of the emitter
10/01/2008CN100422213C Therapeutic binding molecules
10/01/2008CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/01/2008CN100422210C Recombinant protective protein from streptococcus pneumoniae
10/01/2008CN100421727C Methods
09/2008
09/30/2008US7429696 Plants and seeds of hybrid corn variety CH052066
09/30/2008US7429693 Method for the production of plant seed with modified fiber content and modified seed coat
09/30/2008US7429690 Cloned cattle comprising mutations in galactosyltransferase gene sequences which enhanced resistance to bovine spongiform encephalopy; ehancing food safety and quality
09/30/2008US7429657 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
09/30/2008US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease
09/30/2008US7429649 nucleotide sequences encoding the enzymes 4-coumarate CoA-ligase (4CL), cinnamoyl-CoA reductase (CCR), cinnamyl alcohol dehydrogenase (CAD) of the lignin biosynthetic pathway, from ryegrass (Lolium) and fescue (Festuca); transgenic plant
09/30/2008US7429648 IREN protein, its preparation and use
09/30/2008US7429645 Humanized anti-lymphotoxin beta receptor antibodies
09/30/2008US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429640 PRO6181 polypeptides
09/30/2008US7429561 Method for stimulating cell growth using sponge protein hydrolysates
09/30/2008US7429491 Controlling lactic acid production in fed-batch cell cultures via variation in glucose concentration; bioreactors and heterologous gene expression
09/30/2008US7429490 Construction of an artificial uterus; provide biocompatible matrix, prefuse with cell population, culture cells, recover artificial uterine tissue
09/30/2008US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/30/2008US7429488 Method for processing lipoaspirate cells
09/30/2008US7429487 Fusion partner for production of monoclonal rabbit antibodies
09/30/2008US7429486 Recombinant production of mixtures of antibodies
09/30/2008US7429485 Method of producing infectious reovirus
09/30/2008US7429484 Nucleic acid molecules encoding osteogenic proteins
09/30/2008US7429483 Use of nerve growth factor for the storage, culture or treatment of cornea
09/30/2008US7429480 Promoter sequences from WSSV immediate early genes and their uses in recombinant DNA techniques
09/30/2008US7429474 2-O sulfatase compositions and methods of analyzing therewith
09/30/2008US7429473 Diacylglycerol acyltransferase genes, proteins, and uses thereof
09/30/2008US7429468 thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3'-5'-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR.
09/30/2008US7429461 Genetic products differentially expressed in tumors and use thereof
09/30/2008US7429383 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function
09/30/2008US7429382 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
09/30/2008US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/30/2008US7429380 Production of a multimeric protein by cell fusion method
09/30/2008US7429376 Methods of screening for compounds that improve engraftment
09/30/2008US7429374 Determining if a batch of glatiramer acetate is acceptable for pharmaceutical use
09/30/2008CA2473596C Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
09/30/2008CA2434596C Substrates containing polyphosphazene as matrices for producing biological implant materials
09/30/2008CA2328084C Viral production process
09/30/2008CA2309766C Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
09/30/2008CA2261292C Chondrocyte media formulations and culture procedures
09/30/2008CA2259140C Method of activating dendritic cells
09/30/2008CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
09/30/2008CA1341581C Leukaemia inhibitory factor
09/30/2008CA1341580C Tissue-type plasminogen activator mutants
09/26/2008CA2581439A1 Life augmentation
09/25/2008WO2008116213A1 Dermal derived human stem cells and compositions and methods thereof
09/25/2008WO2008116187A1 Systems and methods for anaerobic environmental microbial compartmentalized cultivation
09/25/2008WO2008116157A2 Mesenchymal stem cells and uses therefor
09/25/2008WO2008115254A1 Method of protecting against staphylococcal infection
09/25/2008WO2008115087A1 Process for providing embryonic stem cells
09/25/2008WO2008114902A1 Piglet production method by simultaneous transfer of embryos formed by in vitro fertilization and nuclear transfer
09/25/2008WO2008114892A1 Reductase, gene thereof and method of using the same
09/25/2008WO2008114891A1 Reductase, gene thereof and method of using the same
09/25/2008WO2008114733A1 Anti-claudin-4 antibody
09/25/2008WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation
09/25/2008WO2008114673A1 Method for production of polypeptide
09/25/2008WO2008114672A1 Cancer-specific biomarker
09/25/2008WO2008114544A1 Probe for visualizing cell cycle
09/25/2008WO2008114204A2 A combined scalable in vitro differentiation system for human blastocyst-derived stem (hbs) cells or cells derived from hbs cells for direct assay application in multiwell plates
09/25/2008WO2008113163A1 Transgenic expression of acyl-co-a binding proteins in plants
09/25/2008WO2008084319A3 Novel nucleic acid
09/25/2008WO2008081388A8 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof
09/25/2008WO2008066886A3 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
09/25/2008WO2008021168A3 Rapid-throughput teleost regeneration assay
09/25/2008WO2007058878A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1)
09/25/2008WO2007024391A3 Light-activated cation channel and uses thereof
09/25/2008WO2007014373A3 Novel cells, compositions, and methods
09/25/2008US20080235831 Promoter molecules for use in plants
09/25/2008US20080235828 controllable expression; stably introducing said nucleotide molecule into the genome of a recipient cell from a seed-producing plant;culturing said recipient cell into a whole recipient plant
09/25/2008US20080235826 useful in the production of dwarf plants; type 5 serine/threonine protein phosphatase activity; production of plants sensitive to light signal transduction
09/25/2008US20080235825 Methods and means for modulating cellulose biosynthesis in fiber producing
09/25/2008US20080235823 An isolated nucleic acid molecule that drives and modulates plant transcription having the nucleotide sequence of SEQ ID NO: 2 operably linked to a heterologous nucleic acid sequence; improves root response to varying water conditions, soil environment, tolerance to pests and food nutrition
09/25/2008US20080235822 Nucleic acids encoding chimeric polypeptides allowing expression of plant-noxious proteins
09/25/2008US20080235817 Artificial mammalian chromosome
09/25/2008US20080235816 Multiple inducible gene regulation system
09/25/2008US20080235814 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
09/25/2008US20080234806 Systems and methods of coating a hybrid lower limb artery bypass vascular graft in a mammal
09/25/2008US20080234471 Dna sequence; open-reading frame; genetic engineering
09/25/2008US20080234470 Kcnb: a novel potassium channel protein